Goldman Sachs lowered the firm’s price target on Ibotta (IBTA) to $23 from $26 and keeps a Sell rating on the shares. The “LiveLift” platform transition remains a work in progress, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBTA:
- Ibotta, Inc. Class A: Hold Rating Amid Promising Initiatives and Macroeconomic Challenges
- Cautious Outlook for Ibotta, Inc. Amid Revenue Decline and Uncertain LiveLift Initiative
- Ibotta, Inc. Reports Q3 2025 Financial Results
- Ibotta reports Q3 adjusted EPS 56c, two estimates 34c
- Ibotta sees Q4 revenue $80M-$85M, consensus $84.3M